MEDIA RELEASES
PHARMANIAGA, China's Suzhou Ronnsi Pharma Ink Partnership To Commercialise Malaysia's First Halal Blood Anti-Coagulant
15 JULY 2022
Pharmaniaga Berhad today has entered into a Memorandum of Collaboration with China’s Suzhou Ronnsi Pharma Co., Ltd to commercialise Halal ovine (sheep and goat) anti-coagulant [see more]
PHARMANIAGA STRENGHTENS INDONESIAN MARKET PRESENCE, CONTINUES EXPANDING FOOTPRINT INTO GLOBAL POTENTIAL
13 JUNE 2022
Pharmaniaga Berhad continues to strengthen its presence in the Indonesian market, whilst establishing the Group’s efforts to intensify its position as a major international biopharmaceutical [ see more ]
PHARMANIAGA EMBRACING CAUTIOUSLY BUSINESS PROSPECTS IN FY2022 AMIDST THE UNCERTAIN GLOBAL MARKET
19 MAY 2022
Malaysia’s leading pharmaceutical company, Pharmaniaga Berhad (Pharmaniaga) continues to record growth during the first quarter ended 31 March 2022 (Q1FY2022) despite the [ see more ]
REPORTS
View our latest news and media releases, access our photo and video gallery, our CURE magazine as well as download our Annual and Sustainability Reports.
MEDIA ENQUIRIES
Please contact:
Dato’ Zuhri Iskandar Kamarzaman
Deputy Director
Corporate Services
 |
+603-3342 9999 ext 434 |
 |
+603-3342 6629 |
 |
zuhri@pharmaniaga.com |
 |
Pharmaniaga Berhad
No. 7, Lorong Keluli 1B, Kawasan Perindustrian Bukit Raja Selatan, Seksyen 7, 40000 Shah Alam, Selangor, MALAYSIA |